Showing results (31-40 of 62) with videos related to
Sort By:
Pageof 7
Heart Failure Reviews|October 18, 2011
Systolic heart failure in the elderly: optimizing medical managementJonathan P Man, Bodh I JugduttMolecular and Cellular Biochemistry|March 29, 2005
Apoptosis and oncosis in acute coronary syndromes: assessment and implicationsBodh I Jugdutt, Halliday A IdikioAtherosclerosis|November 5, 2008
Increased burden of coronary artery disease in South-Asians living in North America. Need for an aggressive management algorithmKevin R Bainey, Bodh I JugduttJournal of Cardiac Failure|October 8, 2004
Improved balance between TIMP-3 and MMP-9 after regional myocardial ischemia-reperfusion during AT1 receptor blockadeGrzegorz Sawicki, Vijayan Menon, Bodh I JugduttHeart Failure Reviews|November 5, 2011
Atrial fibrillation and heart failure in the elderlyPedram Kazemian, Gavin Oudit, Bodh I JugduttThe International Journal of Angiology : Official Publication of the International College of Angiology, Inc|April 6, 2012
Large pulmonary artery aneurysm associated with Marfan syndromePeter Ting, Bodh I Jugdutt, Ju Le TanMolecular and Cellular Biochemistry|June 17, 2008
Selective type 1 angiotensin II receptor blockade attenuates oxidative stress and regulates angiotensin II receptors in the canine failing heartGordon Moe, Andrea Konig, Peter Liu, et al.Molecular and Cellular Biochemistry|May 10, 2007
Therapeutic drugs during healing after myocardial infarction modify infarct collagens and ventricular distensibility at elevated pressuresBodh I Jugdutt, Halliday Idikio, Richard R E UwieraMolecular and Cellular Biochemistry|April 12, 2007
Angiotensin receptor blockade and angiotensin-converting-enzyme inhibition limit adverse remodeling of infarct zone collagens and global diastolic dysfunction during healing after reperfused ST-elevation myocardial infarctionBodh I Jugdutt, Halliday Idikio, Richard R E UwieraJournal of the Renin-Angiotensin-Aldosterone System : JRAAS|January 18, 2017
Cardioprotective effects of angiotensin II type 1 receptor blockade with candesartan after reperfused myocardial infarction: role of angiotensin II type 2 receptorBodh I Jugdutt, Yi Xu, Mohammed Balghith, et al.Pageof 7